483
Santosh M. Nair, MDSantosh M. Nair, MD – FDA 483, Feb 26, 2020
Record Details
An FDA inspection of Santosh M. Nair, MD, Clinical Investigator, revealed significant deviations in the conduct of a clinical investigation. The firm failed to adhere to the investigational plan and statement of investigator, maintain adequate drug disposition records, and ensure complete and accurate case histories for study subjects. These findings indicate a lack of control over critical aspects of clinical trial conduct.
View Company Profile
ID · 15b61f59-97d7-447f-a8e7-ed289832afb4
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.